drugset / Trial / NCT00848107
Open-Label Study of Oral Treprostinil in Digital Ulcers
NaSingle-groupOpen-labelTreatment
Summary
This open label extension trial will allow ongoing treatment of subjects who participated in the randomized controlled trials, and will provide long term information about the safety of treprostinil diethanolamine SR in subjects with SSc and digital ulcers.
Timeline
- Start
- 2009-09
- Primary completion
- 2011-09
- Completion
- 2011-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Treprostinil | Other / unclassified | 16 mg | Oral |